Sector
PharmaceuticalsOpen
₹806.5Prev. Close
₹795.55Turnover(Lac.)
₹8.13Day's High
₹819.9Day's Low
₹80052 Week's High
₹955.552 Week's Low
₹635Book Value
₹299.47Face Value
₹10Mkt Cap (₹ Cr.)
382.38P/E
18.05EPS
44.07Divi. Yield
0.0922 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
7 May 2024
12:00 AM
Dividend
Dividend Amount: 0.7
Record Date: 23 Sep, 2024
18 Sep 2024
12:00 AM
AGM
Announcement Date: 18 Sep, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 6.27 | 12.86 | 4.64 | 3.99 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 115.2 | 83.52 | 63.42 | 39.08 |
Net Worth | 121.47 | 96.38 | 68.06 | 43.07 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 133.89 | 112.77 | 58.06 | 56.69 |
yoy growth (%) | 18.72 | 94.2 | 2.41 | 33.96 |
Raw materials | -101.77 | -80.14 | -39.51 | -37.17 |
As % of sales | 76 | 71.06 | 68.04 | 65.57 |
Employee costs | -8.65 | -8.94 | -5.18 | -4.91 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 4.37 | 2.49 | 2.64 | 2.22 |
Depreciation | -2 | -1.87 | -1.28 | -1.13 |
Tax paid | -1.19 | -0.59 | -0.89 | -0.79 |
Working capital | 7.41 | 38.35 | 2.4 | 0.25 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 18.72 | 94.2 | 2.41 | 33.96 |
Op profit growth | 10.51 | 95.94 | 27.02 | -14.89 |
EBIT growth | 23.5 | 50.86 | 11.66 | 3.5 |
Net profit growth | 5.92 | 8.62 | 22.66 | 33.46 |
| Particulars (Rupees in Crores.) | Mar-2025 |
|---|---|
Gross Sales | 451.71 |
Excise Duty | 0 |
Net Sales | 451.71 |
Other Operating Income | 4.56 |
Other Income | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairperson & Joint MD
Daulat N Medhora
Non Executive Director
Nariman B Medhora
Non-Exec. & Independent Dir.
Aspi N Raimalwala
Managing Director & CFO
Fredun N Medhora
Non-Exec. & Independent Dir.
Rohinton Kanga
Non-Exec. & Independent Dir.
Daisy Dsouza
26 Manoj Industrial Premises,
G D Ambedkar Marg Wadala,
Maharashtra - 400031
Tel: 91-22-40318111
Website: http://www.fredungroup.com
Email: business@fredungroup.com
9 ShivShakti Indl Es,
J R Boricha Marg, Lower Parel,
Mumbai - 400 011
Tel: 91-22-23016761/8261
Website: -
Email: -
Summary
Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.94. The Company was promoted by Nariman Medhora and Daulat N Medhora....
Read More
Reports by Fredun Pharmaceuticals Ltd
What is the Fredun Pharmaceuticals Ltd share price today?
What is the Market Cap of Fredun Pharmaceuticals Ltd?
What is the PE and PB ratio of Fredun Pharmaceuticals Ltd?
What is the 52 Week High and Low of Fredun Pharmaceuticals Ltd?
What is the CAGR of Fredun Pharmaceuticals Ltd?
What is the shareholding pattern of Fredun Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.